T0	Participants 32 51	hepatic amoebiasis.
T1	Participants 119 155	31 patients with hepatic amoebiasis.
T2	Participants 156 252	Only those with unequivocal clinical, radiological and laboratory evidence of hepatic amoebiasis
T3	Participants 337 407	15 patients received metronidazole and 16 tinidazole, in random order.
T4	Participants 880 912	hepatic amoebiasis in Bangladesh